How to cite item

Defining the subset of the patients in whom “Less is More” for hormone receptor-positive breast cancer: clinical risk vs. genomics risk

   
@article{TCR12032,
	author = {Yeon Hee Park},
	title = {Defining the subset of the patients in whom “Less is More” for hormone receptor-positive breast cancer: clinical risk vs. genomics risk},
	journal = {Translational Cancer Research},
	volume = {6},
	number = {Suppl 1},
	year = {2017},
	keywords = {},
	abstract = {Omitting adjuvant chemotherapy by risk assessments using clinical and genomic signature is a very important topic for patients and clinician because chemotherapy has potentials to be harmful with various reasons. Currently, NCCN recommend to consider 21-gene RT-PCR assay (1) for patients with hormone receptor-positive breast cancer who have tumor beyond 0.5 cm after curative surgery (2). However, this clinical application of multi-gene assay is not enough to be useful with category 2A level of evidence. In addition, high price of the test is preventing it from becoming widely available.},
	issn = {2219-6803},	url = {https://tcr.amegroups.org/article/view/12032}
}